SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-22-292703
Filing Date
2022-11-28
Accepted
2022-11-25 20:01:02
Documents
12
Period of Report
2022-11-23
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K d425406d8k.htm   iXBRL 8-K 21674
  Complete submission text file 0001193125-22-292703.txt   146119

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA aadi-20221123.xsd EX-101.SCH 2843
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE aadi-20221123_lab.xml EX-101.LAB 18739
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aadi-20221123_pre.xml EX-101.PRE 11703
6 EXTRACTED XBRL INSTANCE DOCUMENT d425406d8k_htm.xml XML 3480
Mailing Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272
Business Address 17383 SUNSET AVENUE SUITE A250 PACIFIC PALISADES CA 90272 424-473-8055
Aadi Bioscience, Inc. (Filer) CIK: 0001422142 (see all company filings)

IRS No.: 611547850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38560 | Film No.: 221420955
SIC: 2834 Pharmaceutical Preparations